No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study
about
Ovarian cancer screening--current status, future directionsSalpingectomy as a means to reduce ovarian cancer riskUnderstanding the needs of women considering risk-reducing salpingo-oophorectomy.The preclinical natural history of serous ovarian cancer: defining the target for early detectionTwo decades after BRCA: setting paradigms in personalized cancer care and preventionDNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk.Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests.Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early DetectionThe Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA CarriersThe effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome.Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening scheduleHigh Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic CounselingEarly detection of ovarian and fallopian tube cancer by examination of cytological samples from the endometrial cavity.Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriersRisk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testingGenomic Biomarkers for Breast Cancer Risk.Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome.Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
P2860
Q27004471-EE38BFDD-458F-4F24-A646-78DFE64B5460Q27011949-1EE2514A-4064-4D30-96FD-3286BFA347C4Q30419497-D59E9F97-5EFC-4B0C-AE4A-54AD2662373BQ33487678-8DE14204-7108-4CDD-A92D-A87194A5AED4Q33820594-21E2A325-6B8D-4F89-A5BE-983262FFE698Q34262449-2F3B166D-D365-4513-BCD6-B17C81CC4B64Q34327275-68F06BCA-FD02-4EDE-89EE-6BCBBB9F803EQ35108393-3B745F2F-7988-4C95-94DB-DC9A36E800BFQ35540547-09FC2382-371A-45D4-938F-F31B339A85E6Q35596203-080DA5EC-BE13-4D58-A74A-EB8DB4145C42Q35749439-70C2E808-113B-455A-A0BF-7927311FD3AAQ36039369-B53B6155-802B-4DCE-AF50-37E345C5E4F6Q36218446-0802CD7D-9E9F-4544-A00B-0C6817BF77CCQ36240959-D2F64307-7F19-4FE6-BFD7-4A798DAFC289Q36313479-52BF202D-1E9B-4EA4-8B45-DB8B6C6DDC5FQ36392688-2AFC81B3-0F18-4CB6-90A4-908447806410Q36490048-1CC1AA93-3579-40E5-B2A0-88BCF8CF0DD7Q36906183-5D0F4F7C-D631-47F0-A159-9FF339CB0478Q37081960-2ED8DC53-9721-440C-AE16-039B2997B25EQ37090813-7A54E99B-08DD-49DE-BCFF-61BC73D39851Q37185670-3C676263-6BDD-47F0-AD44-5138E486160AQ37242239-0B1C5D3E-72F5-45F7-BFE9-4975CD5F817CQ37407195-4A395EA7-503B-43BA-AA9E-D5944485F876Q47958061-9DE137A6-D789-473D-A4CA-70B6D64A2F36
P2860
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
No efficacy of annual gynaecol ...... observational follow-up study
@ast
No efficacy of annual gynaecol ...... observational follow-up study
@en
type
label
No efficacy of annual gynaecol ...... observational follow-up study
@ast
No efficacy of annual gynaecol ...... observational follow-up study
@en
prefLabel
No efficacy of annual gynaecol ...... observational follow-up study
@ast
No efficacy of annual gynaecol ...... observational follow-up study
@en
P2093
P2860
P356
P1476
No efficacy of annual gynaecol ...... observational follow-up study
@en
P2093
B B J Hermsen
C T Brekelmans
C W Burger
G H de Bock
H H van Boven
J A de Hullu
K N Gaarenstroom
L F Massuger
M A Rookus
M J Mourits
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603725
P407
P577
2007-04-10T00:00:00Z
P5875
P6179
1001145193